Clinical Trial Update: A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) [Phase 3]

View source ↗

Summary

Phase 3 trial LATITUDE/SDKARS-301 is evaluating whether oral arsenic trioxide is similar to intravenous arsenic trioxide in pharmacokinetics, safety, and effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Oral arsenic trioxide (arsenic trioxide)
• Trisenox (arsenic trioxide)

Snippet

Sponsor: SDK Therapeutics, Inc. | Conditions: Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia | Phase 3 | Status: NOT_YET_RECRUITING